Capstone Holding Corp. — Director's Dealing 2013

Mar 1, 2013

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2013-02-28

Reporting Person: TAEGER LESLIE M (SVP Chief Financial Officer)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2013-02-28	Stock Option (Right to Buy)	$0.21	A	29000	Acquired	2023-02-28	Common Stock (29000)	Direct

Footnotes

F1: 50% to vest 2/28/13 and 50% to vest 2/28/14